PubMed

Melamede R.

Harm Reduct J. 2005 Sep 22;2:17.

National Toxicology Program.

Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.

Lucas P.

Int J Drug Policy. 2009 Jul;20(4):296-303. Epub 2009 Jan 4.

Bouchard RA.

Health Law J. 2007;15:247-94.

Bates C, Fagerström K, Jarvis MJ, Kunze M, McNeill A, Ramström L.

Tob Control. 2003 Dec;12(4):360-7.

Malfitano AM, Matarese G, Bifulco M.

Curr Drug Targets CNS Neurol Disord. 2005 Dec;4(6):667-75. Review.

Santen RJ, Allred DC, Ardoin SP, Archer DF, Boyd N, Braunstein GD, Burger HG, Colditz GA, Davis SR, Gambacciani M, Gower BA, Henderson VW, Jarjour WN, Karas RH, Kleerekoper M, Lobo RA, Manson JE, Marsden J, Martin KA, Martin L, Pinkerton JV, Rubinow DR, Teede H, Thiboutot DM, Utian WH; Endocrine Society.

J Clin Endocrinol Metab. 2010 Jul;95(7 Suppl 1):s1-s66. Epub 2010 Jun 21. Review.

Warner KE.

Nicotine Tob Res. 2002;4 Suppl 2:S61-71.

Pauly BB.

Int J Drug Policy. 2008 Jun;19(3):195-204. Epub 2008 May 7.

Thomas JD.

Adv Parasitol. 2002;52:1-154. Review.

Reuter P, MacCoun RJ.

Drug Alcohol Rev. 1996 Sep;15(3):225-30.

Sobeyko J.

Ann Acad Med Stetin. 2008;54(2):119-31. Polish.

Pratt BM, Woolfenden SR.

Cochrane Database Syst Rev. 2002;(2):CD002891. Review.

Mouslech Z, Valla V.

Neuro Endocrinol Lett. 2009;30(2):153-79. Review.

McLaren J, Swift W, Dillon P, Allsop S.

Addiction. 2008 Jul;103(7):1100-9. Epub 2008 May 20. Review.

Abel S.

Drug Alcohol Rev. 1997 Dec;16(4):421-8.

Alderman J, Dollar KM, Kozlowski LT.

J Public Health Policy. 2010 Apr;31(1):1-16.

Mountz JD, Zant GV, Allison DB, Zhang HG, Hsu HC.

Mech Ageing Dev. 2002 Apr 30;123(8):963-73. Review.

Ball AL.

Addiction. 2007 May;102(5):684-90.

Pavlinov IIa.

Zh Obshch Biol. 2004 Jul-Aug;65(4):334-66. Russian.